- 37% of the patients had complex anatomies
- 98% freedom from any persistent endoleaks at latest follow-up
- No secondary interventions for Type II endoleaks
- 97% freedom from aneurysm-related mortality
- 99% freedom from cardiovascular mortality
The medical device maker is preparing to break out of a tight triangle pattern.
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.